In conclusion, the present study has provided novel data on the effects of TNFα treatment on AEA catabolic pathways in DU145 prostate cancer cells and suggest that the balance of catabolism is tilted towards COX-2 by this treatment, although the low expression of this enzyme in the cells limits the functional consequence of such a tilt. The gene discussed is TNF; the disease is Familial prostate cancer.